SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-082307
Filing Date
2024-07-09
Accepted
2024-07-09 07:05:21
Documents
14
Period of Report
2024-07-09
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K qttb-20240709.htm   iXBRL 8-K 50245
2 EX-99.1 qttb-ex99_1.htm EX-99.1 27376
3 GRAPHIC img38152436_0.jpg GRAPHIC 3407
4 GRAPHIC img38152436_1.jpg GRAPHIC 3407
  Complete submission text file 0000950170-24-082307.txt   210451

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT qttb-20240709.xsd EX-101.SCH 25022
16 EXTRACTED XBRL INSTANCE DOCUMENT qttb-20240709_htm.xml XML 4727
Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 781-999-0232
Q32 Bio Inc. (Filer) CIK: 0001661998 (see all company filings)

IRS No.: 473468154 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38433 | Film No.: 241106320
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)